Posts tagged Health Canada
Dr. Kimberly Ong of Vireo Advisors, LLC to Present In May 5 NanoCanada Webinar, “Nanotechnology Regulation in Canada, the US, and the EU”

Dr. Kimberly Ong of Vireo Advisors, LLC is pleased to serve on the board of NanoCanada’s Canadian Safety and Health Initiative for Nanotechnology and Advanced Materials and invites you to register for the webinar, “Nanotechnology regulation in Canada, the United States, and the European Union” on May 5, 2021.

Read More
Vireo Advisors Coordinating OECD Workshop to Advance Use of Adverse Outcome Pathways (AOP) for Nanomaterial Risk Assessment

Vireo Advisors is collaborating with Health Canada and two European Horizon2020 projects to coordinate two back-to-back workshops at the OECD: “Advancing Adverse Outcome Pathway (NanoAOP) Development for Nanomaterial Risk Assessment and Categorization” (NanoAOP Workshop), to be held 11 September 2019, and a stakeholder workshop organized by the EU H2020 Project Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS ), to be held 12 September 2019.

Read More
Vireo Advisor's Kimberly Ong to Present Work of NanoAOP Project at Nano Canada 2017 

Dr. Kimberly Ong of Vireo Advisors will present Vireo’s ongoing collaborative work* entitled, "Advancing Adverse Outcome Pathways as a Tool for the Risk Assessment of Nanomaterials – the NanoAOP Project", during NanoCanada's first national conference: Converging on Nanomanufacturing from September 25-26, 2017 in Montréal, Canada. 

Read More
Canada to publish prioritization of nanoscale substances in 2018 

Health Canada and Environment and Climate Change Canada are currently in the process of completing a prioritization of nanomaterials on their Domestic Substances List.

Read More